問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol Number75276617ALE1001
NCT Number(ClinicalTrials.gov Identfier)-
Active

2024-09-01 - 2028-03-01

Phase II

Not yet recruiting1

Recruiting2

ICD-10C95.00

Acute leukemia of unspecified cell type not having achieved remission

ICD-10C95.02

Acute leukemia of unspecified cell type, in relapse

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9208.00

Acute leukemia of unspecified cell type, without mention of remission

-

  • Trial Applicant

    Johnson & Johnson

  • Sponsor

    -

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/05/16

Investigators and Locations

Principal Investigator Tsai-Yun Chen Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Su-Peng Yeh Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator HSIN-AN HOU

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Study Contacts

- -

Condition/Disease

-

Objectives

-

Test Drug

-

Active Ingredient

-

Dosage Form

-

Dosage

-

Endpoints

-

Inclution Criteria

-

Exclusion Criteria

-

The Estimated Number of Participants

  • Taiwan

    15 participants

  • Global

    200 participants